» Articles » PMID: 15922966

Induction of Leukemia-specific CD8+ Cytotoxic T Cells with Autologous Myeloid Leukemic Cells Maturated with a Fiber-modified Adenovirus Encoding TNF-alpha

Overview
Journal Mol Ther
Publisher Cell Press
Date 2005 Jun 1
PMID 15922966
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Acute myeloid leukemia (AML) cells can be differentiated into dendritic cells (DCs) using appropriate combinations of cytokines but generation of autologous antileukemic cytotoxic T cells using leukemic DCs remains difficult. Transduction by adenoviral vectors has been reported to induce efficient maturation of monocyte-derived DCs but AML cells are generally resistant to adenoviral gene transfer. In this study we tested the effects of adenoviral TNF-alpha gene transfer on maturation of AML cells using the fiber-modified AdTNF.F(pK7) adenovirus. All samples expressed high and sustained levels of TNF-alpha following transduction. AdTNF.F(pK7) induced significantly greater maturation of AML cells into antigen-presenting cells (APC) than did recombinant TNF-alpha or control adenoviral vector. Maturation of leukemic cells into APCs was mediated at least partially via a PI3K/mTOR pathway, as the inhibitors LY294002, wortmannin, and rapamycin inhibited the maturation effect induced by the AdTNF.F(pK7) adenovirus. In addition, CD8+ T cells expanded with AdTNF.F(pK7)-transduced AML cells showed greater expansion and specific CD8+ CTL activity against autologous AML cells than T cells expanded by other means. Thus, fiber-modified adenoviral vectors encoding TNF-alpha are able to maturate AML cells into APCs with high efficacy and reproducibility, providing a useful tool to generate efficiently specific CD8+ CTLs against leukemic disease.

Citing Articles

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.

Mercogliano M, Bruni S, Mauro F, Elizalde P, Schillaci R Cancers (Basel). 2021; 13(3).

PMID: 33540543 PMC: 7985780. DOI: 10.3390/cancers13030564.


CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth.

Li G, Wu H, Cui L, Gao Y, Chen L, Li X Oncotarget. 2015; 6(41):43496-507.

PMID: 26554307 PMC: 4791246. DOI: 10.18632/oncotarget.6292.


Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.

Smits E, Lee C, Hardwick N, Brooks S, Van Tendeloo V, Orchard K Cancer Immunol Immunother. 2011; 60(6):757-69.

PMID: 21519825 PMC: 11029703. DOI: 10.1007/s00262-011-1022-6.


In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.

Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N Cancer Immunol Immunother. 2010; 59(12):1839-49.

PMID: 20814675 PMC: 2945474. DOI: 10.1007/s00262-010-0909-y.